Cerus (CERS) Non-Current Assets (2010 - 2026)
Cerus (CERS) reported Non-Current Assets of $47.6 million for Q1 2026, up 5.09% on a YoY basis from $45.3 million in Q1 2025, and little changed sequentially from $47.5 million in Q4 2025.
Cerus (CERS) Non-Current Assets (2010 - 2026) Analysis & Trends
Cerus (CERS) has 17 years of Non-Current Assets data on file, last reported at $47.6 million in Q1 2026.
- For the quarter ending Q1 2026, Non-Current Assets rose 5.09% year-over-year to $47.6 million; the trailing twelve-month figure through Mar 2026 stood at $187.6 million (down 3.05% YoY), and the FY2025 full-year result was $47.5 million, down 2.9% from the prior year.
- Non-Current Assets was little changed at $47.6 million in Q1 2026, from $47.5 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $54.9 million in Q3 2023 to a low of $44.5 million in Q2 2025.
- A 5-year average of $49.1 million and a median of $48.9 million in 2024 frame the typical range for Non-Current Assets.
- Across the five-year window, Non-Current Assets surged 37.6% in 2022 and declined 11.75% in 2025, its largest moves.
- Tracing CERS's Non-Current Assets over 5 years: stood at $47.9 million in 2022, then grew by 11.18% to $53.3 million in 2023, then retreated by 8.28% to $48.9 million in 2024, then retreated by 2.9% to $47.5 million in 2025, then climbed by 0.19% to $47.6 million in 2026.
- Business Quant data shows CERS's Non-Current Assets at $47.6 million in Q1 2026, $47.5 million in Q4 2025, and $48.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 84.92 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 32.95 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 35.67 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 7.09 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 2.30 Bn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 26.70 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | 6.35 Bn |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 20.47 Bn |
| 10 | Cerus | 600.87 Mn | 520.44 Mn | 27.89 Mn | 47.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 47.57 Mn |
| Dec 31, 2025 | 47.48 Mn |
| Sep 30, 2025 | 48.06 Mn |
| Jun 30, 2025 | 44.54 Mn |
| Mar 31, 2025 | 45.26 Mn |
| Dec 31, 2024 | 48.90 Mn |
| Sep 30, 2024 | 48.93 Mn |
| Jun 30, 2024 | 50.47 Mn |
| Mar 31, 2024 | 50.97 Mn |
| Dec 31, 2023 | 53.31 Mn |
| Sep 30, 2023 | 54.91 Mn |
| Jun 30, 2023 | 47.92 Mn |
| Mar 31, 2023 | 47.12 Mn |
| Dec 31, 2022 | 47.95 Mn |
| Sep 30, 2022 | 50.67 Mn |
| Jun 30, 2022 | 51.78 Mn |
| Mar 31, 2022 | 49.09 Mn |
| Dec 31, 2021 | 50.40 Mn |
| Sep 30, 2021 | 40.89 Mn |
| Jun 30, 2021 | 37.63 Mn |